Version Date: Nov 4, 2011 View help for published
Principal Investigator(s): View help for Principal Investigator(s)
Dana Hunt, Abt Associates;
William Rhodes, Abt Associates
Series:
https://doi.org/10.3886/ICPSR32321.v1
Version V1
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 8,332 arrestees were interviewed during the second and third quarters of 2010. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2010, and ending September 30, 2010. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Export Citation:
county
This data collection may not be used for any purpose other than statistical reporting and analysis. Use of these data to learn the identity of any person or establishment is prohibited. To protect respondent privacy, these data are restricted from general dissemination. To obtain this file, researchers must agree to the terms and conditions of a Restricted Data Use Agreement in accordance with existing ICPSR servicing policies
Users are encouraged to read the ADAM II Technical Documentation Report (October 2010) and the ADAM II: 2010 Annual Report for more information.
The Arrestee Drug Abuse Monitoring (ADAM) II program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. ADAM II initiated a new data collection that replicated the methodology used in the first ADAM data collection in order to obtain data comparable to previously established trends.
The Arrestee Drug Abuse Monitoring (ADAM) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). Interviewers worked in teams in each jail. The supervising interviewer drew samples from the stock and flow of male arrestees. When an arrestee was sampled, the supervising interviewer completed a facesheet. The facesheet collected sufficient identifying information that the arrestee could be matched to census data representing all bookings into the jail. The supervising interviewers used the facesheet to record whether the arrestee answered the interview questions and whether he provided a urine specimen. A total of 8,332 arrestees were interviewed during the second and third quarters of 2010. Participation was voluntary and confidential. The average interview lasted 20 minutes with the length of the interview determined by the arrestee's level of drug use and drug market behavior. At the end of the interview, arrestees were asked to provide a urine specimen. The urine specimen was linked to the facesheet through a common barcoded label and analyzed at an off-site central laboratory for recent illegal drug use.
The Arrestee Drug Abuse Monitoring (ADAM) II survey comprised a non-probability sample of counties and a probability sample of arrestees booked into jails within those counties. The sampling design in each facility divided the data collection into periods of stock and flow. Interviewers arrived at the jail at a fixed time during the day, called H, and worked a shift of length S. The stock comprised all arrestees booked between H-24+S and H, and the flow comprised all arrestees booked between H and H+S. The supervising interviewer sampled from the stock and flow. Sampling from the stock required a list of individuals who had been booked since the interviewer's last work period. He or she sought the sampled arrestee, and if that arrestee is unavailable or unwilling to be interviewed, the supervising interviewer sought a replacement. Sampling from the flow required a list of individuals as they are booked into the jail. The supervising interviewer sought the most recently booked arrestee, and if that arrestee is unavailable or unwilling to be interviewed, the supervising interviewer sought a replacement.
All male arrestees in sampled jails in ten counties in the United States during the second and third quarters of 2010.
Representing minimal adjustments to the previously employed ADAM survey, the Arrestee Drug Abuse Monitoring (ADAM) II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Interviews were collected from 4,791 of the 8,332 eligible arrestees sampled across the 10 counties. In 2010, 4,182 of arrestees interviewed voluntarily provided a urine sample for testing.
Hide2011-11-04
2011-11-04 ICPSR data undergo a confidentiality review and are altered when necessary to limit the risk of disclosure. ICPSR also routinely creates ready-to-go data files along with setups in the major statistical software formats as well as standard codebooks to accompany the data. In addition to these procedures, ICPSR performed the following processing steps for this data collection:
The data include two weight variables, WGT_Q (Weights when analyzing interview questions) and WGT_U (Weights when analyzing urine tests).
HideThe public-use data files in this collection are available for access by the general public. Access does not require affiliation with an ICPSR member institution.
One or more files in this data collection have special restrictions. Restricted data files are not available for direct download from the website; click on the Restricted Data button to learn more.
This study is provided by ICPSR. ICPSR provides leadership and training in data access, curation, and methods of analysis for a diverse and expanding social science research community.
